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Recent research has shown that worry is associated with distressing paranoia. Therefore, the aim was to
target worry in a therapeutic intervention for individuals with delusions. It was predicted that a worry
intervention would reduce levels of worry and paranoia distress. Twenty-four individuals with persistent
persecutory delusions and high levels of worry were randomly assigned to receive a four session
cognitive-behavioural worry intervention (W-CBT) or treatment as usual (TAU). The worry intervention
was speciﬁcally designed not to target the content of delusions. In this open-label evaluation, assess-
ments of worry and paranoia were conducted at baseline, at one month (end of treatment) and at two
months. The worry intervention achieved a statistically signiﬁcant reduction in worry which was
maintained at two month follow up. A signiﬁcant reduction in delusional distress was also reported.
There was an indication that the worry intervention may also reduce the frequency of paranoid thoughts
but this was not statistically signiﬁcant. In the ﬁrst trial speciﬁcally for persecutory delusions, a brief
worry intervention was shown to have beneﬁts. The results support a causal role for worry in paranoid
experience.
 2009 Elsevier Ltd.Open access under CC BY license. 1. Introduction
Developments in the understanding of persecutory delusions
have the potential to lead to improvements in treatments. Worry,
deﬁned as ‘a chain of thoughts and images, negatively affect-laden
and relatively uncontrollable’ (Borkovec, Wilkinson, Folensbee, &
Lerman, 1983), is a factor that has recently been implicated in
paranoid experience. Clinical levels of worry are present in almost
two-thirds of individuals with persecutory delusions and the
presence of worry is associated with more distressing delusional
experience (Bassett, Sperlinger, & Freeman, 2009; Freeman &
Garety, 1999; Morrison & Wells, 2007; Startup, Freeman, & Garety,
2007). A catastrophising worry style predicts the occurrence of
non-clinical paranoia and the persistence of persecutory delusions
(Freeman et al., 2008; Startup et al., 2007). Emphasis is placed on
the importance of worry in a cognitive model of persecutory
delusions (Freeman, 2007; Freeman & Freeman, 2008). The
intriguing implication is that treatment of worry in individuals
with persecutory delusions will also lessen paranoia.
Worry has been successfully targeted in people with generalised
anxiety disorder using cognitive-behavioural interventions (seeman).
 license. review by Covin, Ouimet, Seeds, & Dozois, 2008). We aimed to
examine in a small pilot studywhether a brief cognitive-behavioural
worry intervention has the potential to be effective at reducing
levels of worry and delusional distress in individuals with perse-
cutory delusions and clinically signiﬁcant levels of worry. The main
prediction was that the worry intervention would reduce both
worry and paranoia distress compared with treatment as usual.
A secondary hypothesis was that the worry intervention would
reduce the overall occurrence of delusional thoughts. Strengthening
the support for the causal role of worry, it was also predicted that
changes in worry would be associated with changes in paranoia.2. Method
2.1. Participants
The patients with persecutory delusionswere recruited from the
South London and Maudsley NHS Foundation Trust. The inclusion
criteriawere: a current persecutory delusion as deﬁned by Freeman
and Garety (2000); the delusion had persisted at least six months;
a current clinical diagnosis of schizophrenia, schizoaffective
disorderordelusional disorder; a clinically signiﬁcant level ofworry,
as indicated by scores of 45 or more on the PSWQ (Behar, Alcaine,
Zuellig, & Borkovec, 2003; Startup & Erickson, 2006); and aged
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a primary diagnosis of alcohol or substance dependency; organic
syndrome or learning disability; a command of spoken English
inadequate for engaging in psychological therapy; judged as unable
to give informed consent; and currently engaged in any other
individual CBT.
2.2. Design
Participants were randomly allocated to one of two conditions:
a four session worry reduction intervention and treatment as usual
(W-CBT), or treatment as usual (TAU). Participants meeting the
entry criteria were randomly allocated to each condition in
a 1:1 ratio using randomised permuted blocks varying from two to
four (carried out by a researcher independent of the team). Random
allocation followed completion of the baseline assessment (a sealed
envelope was opened). Data were collected at three time points:
at baseline assessment before randomisation, at one month
from randomisation and at two months from randomisation.
The assessments were carried out by the therapist (CF) and were,
therefore, not blind. Ethical approval for the study was obtained
from the Joint South London and Maudsley and the Institute of
Psychiatry NHS Research Ethics Committee. Data collection was
carried out from June 2007 to April 2008.
2.3. Treatment and control conditions
Participants in the W-CBT arm of the trial were offered four
sessions over one month. The worry reduction strategies included
were (i) indicated in the literature to be effective at reducing worry,
either alone or in conjunction with other anxiety management
strategies; (ii) did not challenge or review the delusion itself; and
(iii) had been used by the authors in clinical practice. Key inﬂuences
were Borkovec, Ray, and Stober (1998), Butler, Gelder, Hibbert,
Cullington, and Klimes (1987), Dugas and Ladouceur (1998), Leahy
(2006), and Wells (1997). The main techniques were psycho-
eduction about worry, reviewing of positive and negative beliefs
about worry, increasing awareness of the initiation of worry and
identiﬁcation of individual triggers, learning to ‘let go’ of worry, use
of worry periods, substituting problem-solving in place of worry,
and relaxation exercises. A simple individualised formulation of
each person’s worry was developed and homework between
sessions was agreed. Written informationwas provided in the form
of a leaﬂet called ‘Winning against Worry’. The therapy was
provided by the ﬁrst author under the supervision of the two other
clinical psychologists.
TAU consisted of standard care, delivered according to national
and local service protocols and guidelines. During hospitalisation,
TAU usually involves prescription of anti-psychotic medication,
occupational therapy activities and exercise groups. Following
discharge, the level of TAU varies according to the needs of the
individual. However, this usually consists of prescription of anti-
psychotic medication, visits from a community mental health
worker and monthly outpatient appointments with a psychiatrist.
2.4. Outcome measures
2.4.1. Penn State Worry Questionnaire (PSWQ; Meyer, Miller,
Metzger, & Borkovec, 1990)
The PSWQ is the most established worry questionnaire. It is
designed to capture the generality, excessiveness and uncontrol-
lability of worry. Respondents are asked to indicate how typical
sixteen statements are of them on a ﬁve-point scale, ranging from
‘‘not at all typical of me’’ to ‘‘very typical of me’’. A high score
represents a greater degree of worry. The PSWQ has demonstratedsensitivity to change across both 6-week and 12-week therapeutic
interventions for GAD (Borkovec & Costello, 1993).
2.4.2. Psychotic Symptoms Rating Scale: Delusions Subscale
(PSYRATS; Haddock, McCarron, Tarrier, & Faragher, 1999)
The PSYRATS, increasingly used in psychosis research (e.g. Lewis
et al., 2002), provides a multi-dimensional interviewer rating of
delusional beliefs. Each of the six items are rated on a ﬁve-point
ordinal scale (0–4) and concern the past week. Items on the PSY-
RATS relating to preoccupation, duration, conviction and disruption
load onto Factor 1, labelled ‘cognitive interpretation’, and items
relating to amount and intensity of distress load onto Factor 2,
labelled ‘emotional impact’. The factor structure was conﬁrmed in
a study of over two hundred and ﬁfty individuals presenting with
acute ﬁrst episodes of schizophrenia (Drake, Haddock, Tarrier,
Bentall, & Lewis, 2007).
2.4.3. Green et al. Paranoid Thought Scales (GPTS, Green et al.,
2008)
The GPTS comprises two 16-item scales: Part A, which assesses
social ideas of reference, and Part B, which assesses ideas of
persecution. Respondents are asked to indicate on a ﬁve-point scale
from one (not at all) to ﬁve (totally) how often they have experi-
enced each paranoid thought over the past month. Higher scores
represent a greater degree of delusional ideation. Within the GPTS
are eight-item subscales of conviction, preoccupation, and distress.
Convergent validity of the GPTS with the Paranoia Scale (Fenigstein
& Vanable, 1992) and the Psychotic Symptoms Rating Scale
(Haddock et al., 1999) has been shown.
2.5. Intellectual functioning
2.5.1. Wechsler Test of Adult Reading (WTAR; Wechsler, 2001)
The WTAR was used as an assessment of premorbid intellectual
functioning and consists of 50 words with irregular pronunciations
which the participant is required to read aloud.
2.6. Statistical analysis
The outcomes (PSWQ, PSYRATS, GPTS) at one month and two
months post-randomisationweremodelled by the use of multilevel
linear regression. Multilevel linear regression was used as the data
produced were longitudinal in nature, and participants were
included as a random effect. An advantage of this approach is that it
can easily be used if any data are missing and, therefore, provides
a way to achieve a fully multilevel analysis of repeated measures
with incomplete data (Van Der Leeden, 1998). The models include
the respective baseline measurement to control for pre-treatment
differences, treatment group (represented by one dummy variable),
time (since the one month assessment), and a treatment time
interaction term as an explanatory variable. As an interaction term
was ﬁtted in all models, the coefﬁcient of the treatment group
represented the mean difference between the treatment groups at
the one month assessment adjusting for any baseline differences.
The models were ﬁtted in Stata (version 10) (Stata Corporation,
2007) using the xtmixed command. In all the analyses, a multilevel
model with random intercepts was applied as it was deemed
a more appropriate ﬁt than a random coefﬁcient model due to
reduced standard errors of within and between patient variance in
comparison to the random coefﬁcient model. A full analysis set of
participants was used following ICH topic E9. Randomised partici-
pants were excluded from the full analyses set if they provided no
data post-randomisation. The association between change inworry
and in paranoia was examined using Kendalls’s tau; this non-
parametric measure was used because Kendall’s tau is more robust
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coefﬁcient.2.7. Power analysis
Before the start of the trial, a power analysis was conducted for
change in worry based on the planned analysis detailed above.
This indicted that a sample size of 24 participants (12 in each arm)
would be needed to achieve a clinically important effect size of 0.9,
based on a mean difference between interventions of 9 points and
a common standard deviation of 10 at one and two months in the
primary analysis of the Penn State Worry Questionnaire, at 90%
power and 5% (2 sided) signiﬁcance level. Machin, Campbell, Fayers,
and Pinol (1997) suggest that correlations of 0.6–0.75 between
baseline and outcome measurement are common. Therefore,
a conservative correlation of 0.6 was applied in this sample sizeAssessed for e
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The ﬂow of participants through the trial is shown in Fig. 1.3.1. Demographic and clinical characteristics of the participants
Demographic details are presented in Table 1. The participants
were very similar to those in other studies of persistent psychosis;
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Table 2
Summary statistics for the assessment measures.
Measure Time point W-CBT TAU
N Mean SD N Mean SD
PSWQ
Baseline 12 67.3 9.9 12 62.9 9.1
1 month 9 56.3 13.3 11 62.6 8.7
2 months 10 53.0 14.1 10 62.5 11.3
PSYRATS
Total Baseline 12 17.6 2.0 12 17.8 2.3
1 month 9 14.6 4.2 11 17.8 2.6
2 months 10 14.4 3.8 10 17.3 3.4
Factor 1 (frequency/
duration)
Baseline 12 11.1 1.7 12 11.8 1.8
1 month 9 9.3 2.7 11 11.4 1.9
2 months 10 9.5 2.7 10 11.1 2.4
Factor 2 (distress) Baseline 12 6.5 1.1 12 5.9 1.2
1 month 9 5.2 1.8 11 6.4 1.4
2 months 10 4.9 1.6 10 6.2 1.5
GPTS
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The assessment scores at each timepoint are displayed inTable 2.
Within the W-CBT arm of the trial, mean scores on the Penn
StateWorry Questionnaire reduced by 11.0 points at onemonth and
14.3 points at twomonths compared to baseline scores.Within TAU,
mean worry score on the PSWQ reduced by 0.3 points at the one
month assessment and 0.4 points at the two month assessment.
This is illustrated in Fig. 2. The outcome of the PSWQ at one month
and two months post-randomisation was modelled by a random
intercept multilevel model with patients included as a random
effect (see Table 3). The results indicate that W-CBT reduced worry
by 10.0 points (95% CI: 18.8, 1.2, p¼ 0.025, SE¼ 4.48) in
comparison to TAU adjusting for baseline differences. The results
failed to show a signiﬁcant change in PSWQ by time and by
a treatment time interaction, indicated by non-signiﬁcant p-values.
This indicates that W-CBT reduced worry by ten points in
comparison to TAU post-treatment and this difference was
maintained at two month follow up when accounting for baseline
scores.Total Baseline 12 112.9 23.0 12 100.6 32.7
1 month 9 86.8 41.4 10 89.7 26.1
2 months 10 80.0 40.9 10 100.9 31.7
Part A (social reference) Baseline 12 50.4 15.5 12 47.9 17.1
1 month 9 40.9 22.3 10 41.0 9.3
2 months 10 36.0 21.3 10 48.0 13.5
Part B (persecution) Baseline 12 62.1 12.8 12 52.7 18.2
1 month 9 45.9 21.4 11 49.3 18.1
2 months 10 44.0 21.8 10 52.9 20.3
Distress Baseline 12 28.4 7.8 12 26.9 8.2
1 month 9 21.7 10.4 10 24.1 8.2
2 months 10 20.6 11.0 10 26.3 8.93.3. Intervention effects: paranoia
Within the W-CBT arm of the trial, mean total scores on the
PSYRATS reduced by 3.0 points at one month assessment and
3.2 points at two month assessment as compared to baseline
scores. Within TAU, there was no change in mean total PSYRATS
scores at one month assessment and there was a reduction of
0.5 points at two month assessment compared to baseline scores,
as illustrated in Fig. 2. Fitting a random intercept model indicated
that W-CBT reduced the PSYRATS total score by 2.9 points (95% CI:
5.3, 0.6, p¼ 0.015, SE¼ 1.20) points in comparison to TAU when
adjusting for baseline differences (see Table 3). The results failed to
show a signiﬁcant change in PSYRATS total score by time and byTable 1
The demographic characteristics of the participants.
W-CBT (n¼ 12) TAU (n¼ 12)
Age
Mean age in years 40.0 39.1
Standard deviation 10.0 9.2
Sex (n)
Male 7 (58%) 7 (58%)
Female 5 (42%) 5 (42%)
Ethnicity (n)
White British 4 (33%) 4 (33%)
White other 2 (17%) 0 (0%)
Black British 2 (17%) 5 (42%)
Black African 1 (8%) 3 (25%)
Asian 2 (17%) 0 (0%)
South American 1 (8%) 0 (0%)
Employment (n)
Employed 1 (8%) 1 (8%)
Employed p/t 0 (0%) 1 (8%)
Voluntary employment 1 (8%) 0 (0%)
Unemployed 8 (67%) 9 (75%)
Student 2 (17%) 1 (8%)
Marital status (n)
Single 10 (83%) 11 (92%)
Married 0 (0%) 1 (8%)
Divorced/separated 1 (8%) 0 (0%)
Cohabiting 1 (8%) 0 (0%)
IQ
Mean 98.4 94.2
Standard deviation 8.5 13.6a treatment time interaction indicated by non-signiﬁcant p-values.
Therefore, W-CBT reduced PSYRATS total score by 2.9 points in
comparison to TAU post-treatment and this difference was main-
tained at two month follow up.
Factor 2 (emotional distress) of the PSYRATS offers a summary
score of two distress related items; intensity of distress and amount
of distress. Within the W-CBT arm of the trial, mean distress scores
on the PSYRATS reduced by 1.3 points at onemonth assessment and
1.6 points at two month assessment compared to baseline scores.
Within TAU, there was an increase in mean distress PSYRATS scores
by 0.5 points at onemonth assessment and 0.3 points at twomonth
assessment as compared to baseline scores, as illustrated in Fig. 2.
Fitting a random intercept model showed that W-CBT reduced
PSYRATS Factor 2 by 1.7 points (95% CI:2.8, 0.6, p-value¼ 0.003,
SE¼ 0.57) in comparison to treatment as usual when adjusting for
baseline differences (see Table 3). The results failed to show
a signiﬁcant change in PSYRATS Factor 2 by time and by a treatment
time interaction indicated by non-signiﬁcant p-values. Therefore,
W-CBT reduced Factor 2 scores by 1.7 points in comparison to TAU
post-treatment and this difference was maintained at two months
follow up when accounting for baseline differences.
Within theW-CBTarm of the trial, mean distress subscale scores
on the GPTS reduced by 6.7 points at one month assessment and
7.8 points at two month assessment compared to baseline scores.
Within TAU, mean distress subscale scores on the GPTS reduced by
2.8 points at one month assessment and 0.6 points at two month
assessment compared to baseline scores, as illustrated in Fig. 2.
Fitting a random intercept model for the dependent outcome GPTS
distress subscale indicated that W-CBT failed to show a signiﬁcant
reduction in distress (adjusted mean difference¼4.6, 95% CI:
13.0, 3.8, p¼ 0.285, SE¼ 4.28) compared to TAU when adjusting
for baseline differences (see Table 3).
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Fig. 2. Bar charts showing mean scores (95% CI error bars) for the outcome measures (a) PSWQ scores; (b) PSYRATS: delusions total score; (c) PSYRATS Factor 2 (distress) scores;
(d) GPTS Part B Total Score; (e) GPTS distress score.
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W-CBT arm of the trial, mean Part B scores on the GPTS reduced by
16.2 points at one month assessment and 18.1 points at two month
assessment compared to baseline scores. Within TAU, mean Part B
scores on the GPTS reduced by 3.4 points at the one month assess-
ment and increased by 0.2 points at the two month assessment
compared to scores at baseline assessment, as illustrated in Fig. 2.
Fitting a random intercept model for the dependent outcome GPTS
Part B indicated that W-CBT failed to show a signiﬁcant reduction in
persecutory ideation (adjusted mean difference¼10.5, 95%CI: 28.6, 7.6, p-value¼ 0.255, SE¼ 9.23) in comparison to TAU
adjusting for baseline differences (see Table 3).
3.4. Association of change in worry and paranoia
Associations between changes in worry and changes in perse-
cutory thoughts are reported in Table 4. It can be seen that these
associations were positive and that they mostly reached statistical
signiﬁcance; reductions in worry were associated with reductions
in paranoia.
Table 3
Results of the random intercept multilevel models.
Coefﬁcient SE p-value 95% CI
Worry (PSWQ)
PSWQ baseline 0.79 0.22 <0.001 (0.35, 1.23)
CBT worry intervention 10.00 4.48 0.025 (18.77, 1.23)
Time 0.79 2.46 0.746 (4.02, 5.60)
Time by CBT worry
intervention
5.03 3.57 0.159 (12.03, 1.97)
Constant 14.12 13.99 0.313 (13.29, 41.53)
Between patient SD 7.90 – – –
Within patient SD 5.54 – – –
Intraclass correlation 0.67 – – –
Delusion (PSYRATS)
PSYRATS total score
baseline
1.02 0.24 <0.001 (0.55, 1.50)
CBT worry intervention 2.91 1.20 0.015 (5.27, 0.56)
Time 0.31 0.86 0.722 (2.00, 1.38)
Time by CBT worry
intervention
0.32 1.26 0.802 (2.14, 2.78)
Constant 0.61 4.42 0.891 (9.27, 8.06)
Between patient SD 1.84 – – –
Within patient SD 1.96 – – –
Intraclass correlation 0.47 – – –
Delusion (PSYRATS – Distress)
PSYRATS Factor 2 baseline 0.81 0.20 <0.001 (0.42, 1.20)
CBT worry intervention 1.66 0.57 0.003 (2.77, 0.56)
Time 0.09 0.41 0.826 (0.90, 0.72)
Time by CBT worry
intervention
0.11 0.60 0.851 (1.28, 1.06)
Constant 1.53 1.25 0.224 (0.93, 3.98)
Between patient SD 0.81 – – –
Within patient SD 0.93 – – –
Intraclass correlation 0.43 – – –
Paranoia (GPTS – distress)
Green Paranoid Thoughts
Scale distress score baseline
0.40 0.25 0.107 (0.09, 0.90)
CBT worry intervention 4.58 4.28 0.285 (12.97. 3.82)
Time 2.20 1.76 0.212 (1.26, 5.66)
Time by CBT worry
intervention
2.01 2.56 0.432 (7.03, 3.00)
Constant 13.3 7.31 0.068 (0.99, 27.67)
Between patient SD 8.53 – – –
Within patient SD 3.94 – – –
Intraclass correlation 0.82 – – –
Paranoia (GPTS – Part B)
Green Paranoid Thoughts
Scale Part B baseline
0.39 0.27 0.145 (0.13, 0.91)
CBT worry intervention 10.50 9.23 0.255 (28.59, 7.60)
Time 4.12 3.08 0.181 (1.91, 10.14)
Time by CBT worry
intervention
3.27 4.47 0.465 (12.02, 5.49)
Constant 29.08 15.10 0.054 (0.52, 58.67)
Between patient SD 18.61 – – –
Within patient SD 6.90 – – –
Intraclass correlation 0.87 – – –
Table 4
Association between changes in worry and paranoid thoughts.
Measure n Kentall’s tau p-value
PSWQ baseline
to 1 month
change
GPTS – distress subscale,
change 0–1 month
19 0.329 0.053
PSYRATS – Factor 2 distress
subscale, change 0–1 month
20 0.229 0.196
GPTS Part B (persecutory
thoughts), change 0–1 month
20 0.390 0.018
PSWQ baseline
to 2 month
change
GPTS – distress subscale,
change 0–2 months
20 0.381 0.021
PSYRATS – Factor 2 distress
subscale, change 0–2 months
20 0.488 0.005
GPTS Part B (persecutory
thoughts), change 0–2 months
20 0.342 0.038
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Of the 24 participants in the RCT, 21 were taking anti-psychotic
medication; 10 of the individuals in TAU and 11 of those who
received W-CBT. Within the TAU group, there were no changes in
medication reported during the trial. Within the W-CBT condition,
one participant’s medication was increased by 5 mg and one
participant’s medication was increased by 10 mg per day.3.6. Adverse events
No participant had to be withdrawn from the trial. One partic-
ipant who receivedW-CBT died following the ﬁnal therapy session.This death was from an alcohol-related accidental fall that caused
a major head injury. Suicidal intent was not suspected and the
death was unrelated to the trial.4. Discussion
There is large heterogeneity in the presenting problems of
people with psychosis. We have reduced this complexity by
focussing on one common experience: persecutory delusions.
This is the ﬁrst report of a randomised controlled trial speciﬁcally
for persecutory delusions. A key psychological factor identiﬁed
from the theoretical literature was targeted in a brief therapeutic
intervention. A worry intervention was evaluated for its effects on
both worry and persecutory delusions.
An important outcome on its own is that a reduction in worry
was achieved which was maintained at the short-term follow up.
However, the results also indicated that the worry intervention had
an impact on paranoid experience. Because of the previous research
ﬁndings of an association of worry and persecutory delusion
distress (Bassett et al., 2009; Freeman & Garety, 1999; Morrison &
Wells, 2007; Startup et al., 2007), the analysis focussed upon the
distress associated with paranoia as an outcome. The intervention
achieved a signiﬁcant reduction in persecutory delusions, espe-
cially the associated distress, as assessed by the PSYRATS. The
intervention group also showed reductions on the self-report
paranoia questionnaire, while the control group remained stable,
although these results did not reach statistical signiﬁcance. Less
change would be expected on the self-report paranoia measure
since it concerns the past month (the PSYRATS concerns the past
week) and each participant was only in the trial for a total of two
months. The intervention shows great promise, particularly given
its brevity and the severe experiences reported by the trial patients.
There was a high level of engagement with therapy; all indi-
viduals who started treatment attended all four sessions. The
advantages of a focus on worry are that it does not challenge the
delusion, it targets a problem reported by patients, and by talking
about an experience widely recognised as common in the general
population it is normalising. It may be an extremely helpful
approach before directly addressing the delusional belief. Alterna-
tively, an extended worry intervention, including reviewing, in the
manner of a worry, the likelihood of the persecutory fear occurring,
may alone have signiﬁcant effects.
From a theoretical perspective, it is of note that ﬁnding an effect
of the worry intervention on paranoid experience supports the
cognitivemodel. This was substantiated by ﬁnding an association of
change inworry with change in paranoia. The plausible direction of
the relationship here – because the intervention did not target the
delusion – is that changes in worry produced changes in paranoia.
C. Foster et al. / J. Behav. Ther. & Exp. Psychiat. 41 (2010) 45–51 51The trial demonstrated change in a mechanism, worry, thought to
underlie paranoia, which led to change in persecutory delusions.
However, the pilot study suffered from a number of methodo-
logical weaknesses. The small sample size lessened the power to
detect signiﬁcant changes in paranoia, which was exacerbated by
loss of participants to follow up. It also made it more likely that
there were would be baseline differences between the two groups,
which was seen in the intervention group initially having higher
levels of worry and paranoia. Other important methodological
weaknesses were the absence of blinding of the assessments, the
use of a single therapist, and nomonitoring of therapy adherence or
competence. It would also have been interesting to look at longer
term outcomes. A larger and more methodologically robust trial is
now required.
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